| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5605581 | International Journal of Cardiology | 2017 | 6 Pages |
Abstract
Patients with PAH, but not those with CTEPH, present reduced levels of circulating progenitor cells. PAH-targeted therapy increases levels of progenitors in PAH but not in CTEPH, suggesting different involvement of progenitor cells in the pathobiology of these pulmonary hypertensive disorders.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Jéssica BsC, Olga PhD, Roberto MD, Isabel MD, Sandra MD, Elisabet PhD, Marta PhD, Núria BsC, Lucilla MD, VÃctor I. PhD, Joan Albert MD,